ONYX PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
13 Mar 2013	Form 3: Cagnoni Pablo J, EVP, Global R&D and Tech Ops Holds 0 shares of Common Stock
01 Jun 2012	Form 3: Osborn John E, SVP, Global Corporate Affairs Holds 0 shares of Common Stock
31 Aug 2011	Form 3: Torley Helen, Chief Opertaing Officer Holds 0 shares of Common Stock
07 Feb 2011	Form 3: Ringo William R, Director Holds 0 shares of Common Stock
01 Oct 2010	Form 3: Foster-Cheek Kaye I, SVP, Global Human Resources Holds 0 shares of Common Stock
03 Feb 2010	Form 3: Love Ted W, EVP, R&D Holds 15,350 shares of Common Stock
17 Nov 2009	Form 3: Kauffman Michael, Chief Medical Officer Holds 0 shares of Common Stock
02 Sep 2009	Form 3: Shema Suzanne M, SVP, General Counsel Holds 0 shares of Common Stock
07 Jan 2009	Form 3: Fust Matthew K, Chief Financial Officer Holds 0 shares of Common Stock
07 Oct 2008	Form 3: Batlin Judy A, VP, Org Learning, Dvlpmnt & HR Holds 13,500 shares of Common Stock
20 May 2008	Form 3: Lasowski Juergen, SVP, Corporate Development Holds 0 shares of Common Stock
02 Apr 2008	Form 3: Coles N Anthony, Director Holds 0 shares of Common Stock
13 Jun 2006	Form 3: Brege Laura, EVP and Chief Business Officer No securities owned
19 Apr 2006	Form 3: Schafer Gregory W, Acting CFO Holds 0 shares of No securities held.
07 Oct 2005	Form 3: Lyle Corinne H, Director Holds 0 shares of no securities held
19 Sep 2005	Form 3: Fuchs Henry J, EVP & Chief Medical Officer Holds 0 shares of no securities held
16 Mar 2005	Form 3: Benedetti Fabio M, VP, Medical Affairs
10 Mar 2005	Form 3: Wiggans Thomas G, Director Holds 0 shares of No securities held
27 Sep 2004	Form 3: Kelley Randy Alan, V.P., Sales and Marketing
15 Jun 2004	Form 3: Kenney Edward F, EVP, Chief Business Officer Holds 0 shares of No Securities Held

Comments